Aksoylar, Halil-Ibrahim http://orcid.org/0000-0002-0527-6124
Boussiotis, Vassiliki A. http://orcid.org/0000-0002-3963-1518
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RO1CA212605, RO1CA238263, RO1CA229784)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
First Online: 24 September 2020
Competing interests
: V.A.B. has patents on the PD-1 pathway licensed by Bristol-Myers Squibb, Roche, Merck, EMD-Serono, Boehringer Ingelheim, AstraZeneca, Novartis and Dako. The authors declare no other competing interests.